Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
Radoslaw Kaczmarek, Researcher at IU School of Medicine and Hirszfeld Institute, shared an insightful review on X, reposting from The Video Journal of Hematology and Hematological Oncology:
”Thank you for having me The Video Journal of Hematology and Hematological Oncology.
Several colleagues and I also published a reflective article on this:
I summarized some key points in the video.
SPOILER ALERT
It is not due to lack of interest in gene therapy.”
Read the full article here.
Article: Why is the uptake of gene therapy in hemophilia less than expected?
Authors: Glenn F. Pierce, Mark Skinner, Brian O’Mahony, Dawn Rotellini, Radoslaw Kaczmarek
The Video Journal of Hematology and Hematological Oncology shared on X:
”Why has the uptake of gene therapy in hemophilia been less than expected? Is there limited interest in these therapies?
We caught up with Radoslaw Kaczmarek of Indiana University School of Medicine to get the answers to these questions.”
Watch the full interview.
Stay informed on all scientific advances in the field of genetics with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target